J L Hay - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

European Journal of Pain (London, England)|September 22, 2016

No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test batteryP Okkerse, R Alvarez-Jimenez, J L Hay, et al.

Psycho-Oncology|May 15, 2025

A Multi-Level Analysis of Barriers and Promoting Factors to Cascade Screening Uptake Among Male Relatives of BRCA1/2 Carriers: A Qualitative StudyG Ongaro, J G Hamilton, V Groner, et al.

Hepatology (Baltimore, Md.)|March 25, 2000

Host genetic factors influence disease progression in chronic hepatitis CE E Powell, C J Edwards-Smith, J L Hay, et al.

Clinical and Translational Science|October 16, 2016

Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium LabelingKms Kanhai, S C Goulooze, J Stevens, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

European Journal of Pain (London, England)|September 22, 2016

No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test batteryP Okkerse, R Alvarez-Jimenez, J L Hay, et al.

Psycho-Oncology|May 15, 2025

A Multi-Level Analysis of Barriers and Promoting Factors to Cascade Screening Uptake Among Male Relatives of BRCA1/2 Carriers: A Qualitative StudyG Ongaro, J G Hamilton, V Groner, et al.

Hepatology (Baltimore, Md.)|March 25, 2000

Host genetic factors influence disease progression in chronic hepatitis CE E Powell, C J Edwards-Smith, J L Hay, et al.

Clinical and Translational Science|October 16, 2016

Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium LabelingKms Kanhai, S C Goulooze, J Stevens, et al.

Pageof 2